| Kari Schnaars, | |
|
111 Colchester Ave, Burlington, VT 05401-1473 | |
| (802) 847-0000 | |
| Not Available |
| Full Name | Kari Schnaars |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 10 Years |
| Location | 111 Colchester Ave, Burlington, Vermont |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255749651 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363AM0700X | Physician Assistant - Medical | 055.0031216 (Vermont) | Secondary |
| 363A00000X | Physician Assistant | 055.0031635 (Vermont) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Univ. Of Vermont - Fletcher Allen Health Care | Burlington, VT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Vermont Medical Center Inc | 3779491071 | 994 |
News Archive
Life Technologies Corporation today announced early stage results from its single molecule sequencing (SMS) technology. The technology promises to combine virtually unlimited continuous long read lengths with unmatched accuracy to deliver targeted genomic sequence data in a matter of hours, paving the way for sequencing to become a commonplace tool in research laboratories and clinical settings worldwide.
A team of scientists that included researchers from UCLA has discovered a novel mechanism of RNA regulation in embryonic stem cells. The findings are strong evidence that a specific chemical modification, or "tag," on RNA plays a key role in determining the ability of embryonic stem cells to adopt different cellular identities.
When infected by a virus, a cell uses specific defense mechanisms developed in the course of a long evolution. Thus, it can activate enzymes that disrupt or prevent replication of the viruses within the cell.
Inhibitex, Inc. today announced that the independent data safety monitoring board (DSMB) responsible for reviewing safety data from the Company's ongoing Phase II clinical trial of FV-100 met, as scheduled, after the Company had provided it with complete 30-day follow-up safety data on the third quartile (75%) of the patients that the Company plans to enroll in the trial. Based upon its review, the DSMB recommended that the trial continue to completion without modification.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kari Schnaars, 111 Colchester Ave, Burlington, VT 05401-1473 Ph: (802) 847-0000 | Kari Schnaars, 111 Colchester Ave, Burlington, VT 05401-1473 Ph: (802) 847-0000 |
News Archive
Life Technologies Corporation today announced early stage results from its single molecule sequencing (SMS) technology. The technology promises to combine virtually unlimited continuous long read lengths with unmatched accuracy to deliver targeted genomic sequence data in a matter of hours, paving the way for sequencing to become a commonplace tool in research laboratories and clinical settings worldwide.
A team of scientists that included researchers from UCLA has discovered a novel mechanism of RNA regulation in embryonic stem cells. The findings are strong evidence that a specific chemical modification, or "tag," on RNA plays a key role in determining the ability of embryonic stem cells to adopt different cellular identities.
When infected by a virus, a cell uses specific defense mechanisms developed in the course of a long evolution. Thus, it can activate enzymes that disrupt or prevent replication of the viruses within the cell.
Inhibitex, Inc. today announced that the independent data safety monitoring board (DSMB) responsible for reviewing safety data from the Company's ongoing Phase II clinical trial of FV-100 met, as scheduled, after the Company had provided it with complete 30-day follow-up safety data on the third quartile (75%) of the patients that the Company plans to enroll in the trial. Based upon its review, the DSMB recommended that the trial continue to completion without modification.
› Verified 5 days ago
Dr. Kristen M. Daniels, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave., Uvm Medical Center - Surgery/plastics, Burlington, VT 05401 Phone: 802-847-3340 Fax: 802-847-7083 | |
Kimberly Ann Holbrook, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, 354mp2, Burlington, VT 05401 Phone: 802-847-3496 Fax: 802-847-0574 | |
Mrs. Cheryl Gagnon, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-864-0111 | |
Kirsten Lanpher, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-4590 Fax: 802-847-0654 | |
Ms. Christine Yvette O'neill, P.A. Physician Assistant Medicare: Medicare Enrolled Practice Location: 111 Colchester Ave, Fahc Radiology Department, Burlington, VT 05401 Phone: 802-847-8359 | |
Oliver Barkley, Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, 205wp1, Burlington, VT 05401 Phone: 802-847-3982 | |
Nicole Kimball, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 173 Saint Paul St, Burlington, VT 05401 Phone: 866-476-1321 |